Journal of Orthopaedic Surgery and Research, 2020 · DOI: https://doi.org/10.1186/s13018-020-01727-1 · Published: May 25, 2020
Spinal cord injury (SCI) often leads to the disruption of axonal tracts and is a major cause of disability. After the initial injury, a cascade of events including inflammation can lead to neurological disorders. Inflammation in the early stages of SCI can promote recovery, while premature inhibition of inflammation might worsen the damage. Different types of inflammatory cells play different roles in neuroprotection. This study suggests that higher serum levels of IL-4 and IL-10 can reflect the restorability degree of SCI and could be potential biomarkers for the prognosis of SCI.
Serum levels of IL-4 and IL-10 may serve as serologic markers to forecast SCI prognosis.
Promoting macrophage polarization from M1 to M2 may enhance axonal regeneration.
Modulating the inflammatory response may improve outcomes after spinal cord injury.